HEADER SIGNALING PROTEIN/INHIBITOR 26-NOV-11 4A9O TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ETHYL-3-METHYL-4-PHENYL-1, TITLE 2 2-OXAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN CONTAINING 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN (BD1), RESIDUES 67-200; COMPND 5 SYNONYM: HUMAN BRD2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SIGNALING PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.W.CHUNG,P.BAMBOROUGH REVDAT 2 08-MAY-24 4A9O 1 REMARK REVDAT 1 08-FEB-12 4A9O 0 JRNL AUTH P.BAMBOROUGH,H.DIALLO,J.D.GOODACRE,L.GORDON,A.LEWIS, JRNL AUTH 2 J.T.SEAL,D.M.WILSON,M.D.WOODROW,C.W.CHUNG JRNL TITL FRAGMENT-BASED DISCOVERY OF BROMODOMAIN INHIBITORS PART 2: JRNL TITL 2 OPTIMIZATION OF PHENYLISOXAZOLE SULFONAMIDES. JRNL REF J.MED.CHEM. V. 55 587 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22136469 JRNL DOI 10.1021/JM201283Q REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 38647 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1614 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.78 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.83 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2586 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE SET COUNT : 114 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2763 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 417 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.97000 REMARK 3 B22 (A**2) : -0.45000 REMARK 3 B33 (A**2) : -0.78000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.83000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.115 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.106 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.067 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.557 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3047 ; 0.005 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2068 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4144 ; 0.853 ; 1.947 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5066 ; 0.770 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 357 ; 3.985 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 145 ;36.158 ;25.034 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 555 ;10.916 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;22.286 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 426 ; 0.048 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3346 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 607 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1758 ; 0.624 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 675 ; 0.068 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2888 ; 1.224 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1289 ; 1.382 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1256 ; 2.236 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 74 A 188 REMARK 3 ORIGIN FOR THE GROUP (A): 15.7677 6.5514 2.0666 REMARK 3 T TENSOR REMARK 3 T11: 0.0218 T22: 0.0225 REMARK 3 T33: 0.0518 T12: 0.0110 REMARK 3 T13: 0.0157 T23: 0.0009 REMARK 3 L TENSOR REMARK 3 L11: 0.8642 L22: 0.4469 REMARK 3 L33: 0.7929 L12: -0.3457 REMARK 3 L13: -0.1293 L23: 0.0125 REMARK 3 S TENSOR REMARK 3 S11: -0.0475 S12: -0.0306 S13: -0.0675 REMARK 3 S21: 0.0278 S22: 0.0248 S23: 0.0594 REMARK 3 S31: -0.0044 S32: -0.0431 S33: 0.0227 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 76 B 183 REMARK 3 ORIGIN FOR THE GROUP (A): 34.7843 8.7364 10.5256 REMARK 3 T TENSOR REMARK 3 T11: 0.0309 T22: 0.0085 REMARK 3 T33: 0.0523 T12: 0.0085 REMARK 3 T13: -0.0189 T23: -0.0003 REMARK 3 L TENSOR REMARK 3 L11: 0.6150 L22: 0.8215 REMARK 3 L33: 1.0970 L12: -0.2785 REMARK 3 L13: -0.0839 L23: 0.0647 REMARK 3 S TENSOR REMARK 3 S11: -0.0109 S12: -0.0487 S13: 0.0133 REMARK 3 S21: 0.0530 S22: 0.0634 S23: -0.0697 REMARK 3 S31: -0.0142 S32: -0.0064 S33: -0.0525 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 76 C 182 REMARK 3 ORIGIN FOR THE GROUP (A): -1.7522 18.9089 23.6052 REMARK 3 T TENSOR REMARK 3 T11: 0.0165 T22: 0.0901 REMARK 3 T33: 0.0069 T12: 0.0115 REMARK 3 T13: 0.0068 T23: 0.0063 REMARK 3 L TENSOR REMARK 3 L11: 0.3128 L22: 1.4948 REMARK 3 L33: 1.7223 L12: -0.0371 REMARK 3 L13: 0.7287 L23: -0.2242 REMARK 3 S TENSOR REMARK 3 S11: -0.0371 S12: 0.0158 S13: -0.0199 REMARK 3 S21: -0.1079 S22: 0.0866 S23: -0.0185 REMARK 3 S31: -0.0541 S32: 0.0588 S33: -0.0495 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4A9O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-NOV-11. REMARK 100 THE DEPOSITION ID IS D_1290050494. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-OCT-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40262 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 67.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.0, 22-26% PEG 3350, REMARK 280 0.2 M (NH4)2SO4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.81400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.84600 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.81400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.84600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -4.74881 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 67.91117 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C2080 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 47 REMARK 465 SER A 48 REMARK 465 SER A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 SER A 56 REMARK 465 SER A 57 REMARK 465 GLY A 58 REMARK 465 LEU A 59 REMARK 465 VAL A 60 REMARK 465 PRO A 61 REMARK 465 ARG A 62 REMARK 465 GLY A 63 REMARK 465 SER A 64 REMARK 465 HIS A 65 REMARK 465 MET A 66 REMARK 465 SER A 67 REMARK 465 ASN A 68 REMARK 465 PRO A 69 REMARK 465 LYS A 70 REMARK 465 LYS A 71 REMARK 465 PRO A 72 REMARK 465 GLY A 73 REMARK 465 VAL A 189 REMARK 465 THR A 190 REMARK 465 ILE A 191 REMARK 465 PRO A 192 REMARK 465 LYS A 193 REMARK 465 ASN A 194 REMARK 465 SER A 195 REMARK 465 HIS A 196 REMARK 465 LYS A 197 REMARK 465 LYS A 198 REMARK 465 GLY A 199 REMARK 465 ALA A 200 REMARK 465 GLY B 47 REMARK 465 SER B 48 REMARK 465 SER B 49 REMARK 465 HIS B 50 REMARK 465 HIS B 51 REMARK 465 HIS B 52 REMARK 465 HIS B 53 REMARK 465 HIS B 54 REMARK 465 HIS B 55 REMARK 465 SER B 56 REMARK 465 SER B 57 REMARK 465 GLY B 58 REMARK 465 LEU B 59 REMARK 465 VAL B 60 REMARK 465 PRO B 61 REMARK 465 ARG B 62 REMARK 465 GLY B 63 REMARK 465 SER B 64 REMARK 465 HIS B 65 REMARK 465 MET B 66 REMARK 465 SER B 67 REMARK 465 ASN B 68 REMARK 465 PRO B 69 REMARK 465 LYS B 70 REMARK 465 LYS B 71 REMARK 465 PRO B 72 REMARK 465 GLY B 73 REMARK 465 ARG B 74 REMARK 465 VAL B 75 REMARK 465 GLU B 184 REMARK 465 GLN B 185 REMARK 465 GLU B 186 REMARK 465 LEU B 187 REMARK 465 VAL B 188 REMARK 465 VAL B 189 REMARK 465 THR B 190 REMARK 465 ILE B 191 REMARK 465 PRO B 192 REMARK 465 LYS B 193 REMARK 465 ASN B 194 REMARK 465 SER B 195 REMARK 465 HIS B 196 REMARK 465 LYS B 197 REMARK 465 LYS B 198 REMARK 465 GLY B 199 REMARK 465 ALA B 200 REMARK 465 GLY C 47 REMARK 465 SER C 48 REMARK 465 SER C 49 REMARK 465 HIS C 50 REMARK 465 HIS C 51 REMARK 465 HIS C 52 REMARK 465 HIS C 53 REMARK 465 HIS C 54 REMARK 465 HIS C 55 REMARK 465 SER C 56 REMARK 465 SER C 57 REMARK 465 GLY C 58 REMARK 465 LEU C 59 REMARK 465 VAL C 60 REMARK 465 PRO C 61 REMARK 465 ARG C 62 REMARK 465 GLY C 63 REMARK 465 SER C 64 REMARK 465 HIS C 65 REMARK 465 MET C 66 REMARK 465 SER C 67 REMARK 465 ASN C 68 REMARK 465 PRO C 69 REMARK 465 LYS C 70 REMARK 465 LYS C 71 REMARK 465 PRO C 72 REMARK 465 GLY C 73 REMARK 465 ARG C 74 REMARK 465 VAL C 75 REMARK 465 GLU C 183 REMARK 465 GLU C 184 REMARK 465 GLN C 185 REMARK 465 GLU C 186 REMARK 465 LEU C 187 REMARK 465 VAL C 188 REMARK 465 VAL C 189 REMARK 465 THR C 190 REMARK 465 ILE C 191 REMARK 465 PRO C 192 REMARK 465 LYS C 193 REMARK 465 ASN C 194 REMARK 465 SER C 195 REMARK 465 HIS C 196 REMARK 465 LYS C 197 REMARK 465 LYS C 198 REMARK 465 GLY C 199 REMARK 465 ALA C 200 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 123 CG - SD - CE ANGL. DEV. = -9.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2003 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A2112 DISTANCE = 6.79 ANGSTROMS REMARK 525 HOH B2073 DISTANCE = 7.14 ANGSTROMS REMARK 525 HOH C2069 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH C2070 DISTANCE = 6.95 ANGSTROMS REMARK 525 HOH C2101 DISTANCE = 8.83 ANGSTROMS REMARK 525 HOH C2103 DISTANCE = 7.37 ANGSTROMS REMARK 525 HOH C2104 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH C2105 DISTANCE = 6.52 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1189 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A9O A 1190 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1191 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1192 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 1184 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A9O B 1185 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A9O C 1183 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 1184 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2YEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GSK525762 (IBET) REMARK 900 RELATED ID: 4A9E RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9H RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2- METHYL-1,2,3,4- REMARK 900 TETRAHYDROQUINOLIN-1-YL)ETHAN-1-ONE REMARK 900 RELATED ID: 4A9M RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N- CYCLOPENTYL-5-(3,5- REMARK 900 DIMETHYL-1,2-OXAZOL-4-YL)-2- METHYLBENZENE-1-SULFONAMIDE REMARK 900 RELATED ID: 4A9F RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1- METHYLPYRROLIDIN-2-ONE REMARK 900 RELATED ID: 2YDW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GW841819X REMARK 900 RELATED ID: 4A9J RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4- HYDROXYPHENYL) REMARK 900 ACETAMIDE REMARK 900 RELATED ID: 1X0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OFHUMAN REMARK 900 BRD2 REMARK 900 RELATED ID: 4A9I RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE DBREF 4A9O A 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4A9O B 67 200 UNP P25440 BRD2_HUMAN 67 200 DBREF 4A9O C 67 200 UNP P25440 BRD2_HUMAN 67 200 SEQADV 4A9O GLY A 47 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER A 48 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER A 49 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 50 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 51 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 52 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 53 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 54 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 55 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER A 56 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER A 57 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY A 58 UNP P25440 EXPRESSION TAG SEQADV 4A9O LEU A 59 UNP P25440 EXPRESSION TAG SEQADV 4A9O VAL A 60 UNP P25440 EXPRESSION TAG SEQADV 4A9O PRO A 61 UNP P25440 EXPRESSION TAG SEQADV 4A9O ARG A 62 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY A 63 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER A 64 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS A 65 UNP P25440 EXPRESSION TAG SEQADV 4A9O MET A 66 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY B 47 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER B 48 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER B 49 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 50 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 51 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 52 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 53 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 54 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 55 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER B 56 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER B 57 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY B 58 UNP P25440 EXPRESSION TAG SEQADV 4A9O LEU B 59 UNP P25440 EXPRESSION TAG SEQADV 4A9O VAL B 60 UNP P25440 EXPRESSION TAG SEQADV 4A9O PRO B 61 UNP P25440 EXPRESSION TAG SEQADV 4A9O ARG B 62 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY B 63 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER B 64 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS B 65 UNP P25440 EXPRESSION TAG SEQADV 4A9O MET B 66 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY C 47 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER C 48 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER C 49 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 50 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 51 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 52 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 53 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 54 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 55 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER C 56 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER C 57 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY C 58 UNP P25440 EXPRESSION TAG SEQADV 4A9O LEU C 59 UNP P25440 EXPRESSION TAG SEQADV 4A9O VAL C 60 UNP P25440 EXPRESSION TAG SEQADV 4A9O PRO C 61 UNP P25440 EXPRESSION TAG SEQADV 4A9O ARG C 62 UNP P25440 EXPRESSION TAG SEQADV 4A9O GLY C 63 UNP P25440 EXPRESSION TAG SEQADV 4A9O SER C 64 UNP P25440 EXPRESSION TAG SEQADV 4A9O HIS C 65 UNP P25440 EXPRESSION TAG SEQADV 4A9O MET C 66 UNP P25440 EXPRESSION TAG SEQRES 1 A 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 A 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 A 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 A 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 A 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 A 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 A 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 A 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 A 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 A 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 A 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 B 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 B 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 B 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 B 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 B 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 B 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 B 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 B 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 B 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 B 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 B 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 B 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA SEQRES 1 C 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 C 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 C 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 C 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 C 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 C 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 C 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 C 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 C 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 C 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 C 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 C 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA HET EDO A1189 4 HET A9O A1190 14 HET SO4 A1191 5 HET SO4 A1192 5 HET EDO B1184 4 HET A9O B1185 14 HET A9O C1183 14 HET SO4 C1184 5 HETNAM EDO 1,2-ETHANEDIOL HETNAM A9O 5-ETHYL-3-METHYL-4-PHENYL-1,2-OXAZOLE HETNAM SO4 SULFATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 4 EDO 2(C2 H6 O2) FORMUL 5 A9O 3(C12 H13 N O) FORMUL 6 SO4 3(O4 S 2-) FORMUL 12 HOH *417(H2 O) HELIX 1 1 THR A 76 VAL A 85 1 10 HELIX 2 2 VAL A 85 LYS A 92 1 8 HELIX 3 3 ALA A 96 ARG A 100 5 5 HELIX 4 4 ASP A 104 GLY A 109 1 6 HELIX 5 5 ASP A 112 ILE A 117 1 6 HELIX 6 6 ASP A 122 ASN A 132 1 11 HELIX 7 7 ALA A 137 ASN A 156 1 20 HELIX 8 8 ASP A 160 ALA A 178 1 19 HELIX 9 9 THR B 76 VAL B 85 1 10 HELIX 10 10 VAL B 85 LYS B 92 1 8 HELIX 11 11 ALA B 96 ARG B 100 5 5 HELIX 12 12 ASP B 112 ILE B 117 1 6 HELIX 13 13 ASP B 122 ASN B 132 1 11 HELIX 14 14 ALA B 137 ASN B 156 1 20 HELIX 15 15 ASP B 160 ALA B 178 1 19 HELIX 16 16 THR C 76 VAL C 85 1 10 HELIX 17 17 VAL C 85 LYS C 92 1 8 HELIX 18 18 ALA C 96 ARG C 100 5 5 HELIX 19 19 ASP C 112 ILE C 117 1 6 HELIX 20 20 ASP C 122 ASN C 132 1 11 HELIX 21 21 ALA C 137 ASN C 156 1 20 HELIX 22 22 ASP C 160 SER C 179 1 20 SITE 1 AC1 5 GLN A 94 HOH A2032 HOH A2176 HOH A2177 SITE 2 AC1 5 TRP B 97 SITE 1 AC2 7 PRO A 98 PHE A 99 LEU A 110 TYR A 155 SITE 2 AC2 7 ASN A 156 HOH A2082 EDO B1184 SITE 1 AC3 4 ARG A 100 HOH A2024 HOH A2027 HOH A2029 SITE 1 AC4 3 ARG A 128 ARG A 129 HOH A2115 SITE 1 AC5 6 TRP A 97 A9O A1190 GLN B 94 HOH B2019 SITE 2 AC5 6 HOH B2129 HOH B2130 SITE 1 AC6 6 PRO B 98 PHE B 99 LEU B 110 TYR B 155 SITE 2 AC6 6 ASN B 156 HOH B2045 SITE 1 AC7 5 PRO C 98 LEU C 110 TYR C 155 ASN C 156 SITE 2 AC7 5 HOH C2036 SITE 1 AC8 7 ARG B 100 ARG C 128 ASN C 132 TYR C 134 SITE 2 AC8 7 HOH C2060 HOH C2099 HOH C2100 CRYST1 113.628 55.692 68.077 90.00 94.00 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008801 0.000000 0.000615 0.00000 SCALE2 0.000000 0.017956 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014725 0.00000